6810 Share Price Performance
NT$23.90
-10.25 (-30.01%)
Price NT$23.90
Share PriceNT$23.90
Bio Preventive Medicine Corp. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
6810 Community Narratives
There are no narratives available yet.
Recent 6810 News & Updates
Bio Preventive Medicine Corp. Key Details
Last Reported Earnings
n/a
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Bio Preventive Medicine Corp. Competitors
Snowflake Analysis
About 6810
- Founded
- 2014
- Employees
- n/a
- CEO
- WebsiteView website
Bio Preventive Medicine Corp, a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It provides DNlite test, a series of patented and clinically validated non-invasive urine test for diabetic kidney disease management, such as DNlite-IVD103 and DNlite-DN_Score. The company was founded in 2014 and is headquartered in Zhubei, Taiwan.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Taiwanese Market Performance
- 7 Days: 5.0%
- 3 Months: 20.1%
- 1 Year: 18.3%
- Year to Date: 18.0%
Over the last 7 days, the market has risen 5.0%, driven by gains of 7.3% in the Information Technology sector. In the last year, the market has climbed 18%. Earnings are forecast to grow by 18% annually. Market details ›